Posted by: Dal Watson | December 1, 2010

IRS issues guidance to manufacturers & importers of branded prescription drugs on annual fee to be imposed by the health care reform law:

- An article from Employee Benefit News


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

Follow

Get every new post delivered to your Inbox.

Join 2,646 other followers

%d bloggers like this: